Ainos, Inc. Files 8-K Report

Ticker: AIMDW · Form: 8-K · Filed: Mar 5, 2025 · CIK: 1014763

Sentiment: neutral

Topics: 8-K, corporate-filing, pharmaceuticals

Related Tickers: AIMD

TL;DR

Ainos, Inc. (AIMD) filed an 8-K on March 5, 2025, updating on corporate events and financials.

AI Summary

On March 5, 2025, Ainos, Inc. filed an 8-K report detailing other events and financial statements/exhibits. The company, formerly known as Amarillo Biosciences Inc., is incorporated in Texas and operates in the pharmaceutical preparations sector.

Why It Matters

This filing provides an update on Ainos, Inc.'s corporate activities and financial reporting, which is crucial for investors to assess the company's current status.

Risk Assessment

Risk Level: low — The filing is a routine 8-K report and does not appear to contain any immediately alarming or significant negative news.

Key Numbers

Key Players & Entities

FAQ

What specific 'Other Events' are detailed in the 8-K filing?

The provided text does not specify the 'Other Events', only that they are part of the 8-K filing.

What is the SIC code for Ainos, Inc.?

The Standard Industrial Classification (SIC) code for Ainos, Inc. is 2834, which corresponds to Pharmaceutical Preparations.

When did Ainos, Inc. change its name from Amarillo Biosciences Inc.?

The date of the name change from Amarillo Biosciences Inc. to Ainos, Inc. was May 16, 1996.

What is the business address of Ainos, Inc.?

The business address of Ainos, Inc. is 8880 Rio San Diego Drive, Suite 800, San Diego, CA 92108.

What is the fiscal year end for Ainos, Inc.?

The fiscal year end for Ainos, Inc. is December 31 (1231).

Filing Details

This Form 8-K (Form 8-K) was filed with the SEC on March 5, 2025 regarding Ainos, Inc. (AIMDW).

View full filing on EDGAR

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing